Burkitt Lymphoma After Cardiac Transplantation: Therapeutic Considerations
We report an 8-year-old boy with a history of heart transplant who developed Epstein-Barr virus positive, late-onset PSOT-BL. He was successfully treated with BL specific chemoimmunotherapy and cessation of baseline immunosuppression. In this pediatric case of PSOT-BL, the use of standard intensive pediatric based chemoimmunotherapy regimen without modifications was feasible, well tolerated and resulted in complete remission. Long-term toxicities need further study.
Source: Journal of Pediatric Hematology Oncology - Category: Hematology Tags: Clinical and Laboratory Observations Source Type: research
More News: Burkitt Lymphoma | Cancer & Oncology | Cardiology | Heart | Heart Transplant | Hematology | Laboratory Medicine | Lymphoma | Pediatrics | Study | Toxicology | Transplant Surgery | Transplants